Latest Results

INTERIM RESULTS For the 6 months ended 29 February 2024

Carr’s Group plc (CARR.L), (‘’Carr’s”, the ‘’Company’’, or the ‘’Group’’) the Agriculture and Engineering Group, announces a strategic update and its un-audited interim results for the six months ended 29 February 2024.

Download

The full results are available to download in 
PDF format

Strategic Update

Following the review of the performance, composition and organisation of the Group’s operations highlighted at the time of the Full Year Results announcement (‘’FY23’’) on 21 December 2023 the Board has concluded that continuing with two divisions (Agriculture and Engineering) is an inefficient operating model, particularly given the lack of synergistic benefits and resultant central overheads, both of which are dilutive to management’s and investment focus.

The Board believes that both the Engineering Division and the Agriculture Division hold material value creation opportunities; however, the Agriculture Division will be optimised in the medium term through transformation plans developed and implemented by recently appointed management, whilst the Engineering Division represents a near-term opportunity.

The Board is therefore running a process to explore options to maximise shareholder value with regard to the Engineering Division.

Further updates will be provided when appropriate.

Interim Results for the 6 months ended 29 February 2024

Financial Highlights

Adjusted (Continuing Operations) H1 2024 H1 2023 (restated) +/-%
Revenue (£’m)81.4 79.8 +2.0
Adjusted operating profit (£’m)5.8 5.8 -1.4
Adjusted profit before tax (£’m)5.6 5.6 +0.6
Adjusted earnings per share (p)4.8 5.0 -4.0
   
Statutory (Continuing Operations) H1 2024 H1 2023 (restated) +/-%
Revenue (£’m)81.4 79.8 +2.0
Operating profit (£’m) 3.5 5.2 -32.1
Profit before tax (£’m) 3.4 5.0 -31.3
Basic earnings per share (p) 3.0 4.5 -33.3
Interim dividend per share (p) 2.35 1.175 +100.0
 
Net cash (£’m) 8.0 8.6  
    

 

Highlights

  • Engineering Division
    • Continued strong performance with revenues for the six month period increased by 26.1% to £28.5m (H1 2023: £22.6m).
    • Adjusted operating profit for the six month period increased by 119.2% to £2.4m (H1 2023: £1.1m).
    • Adjusted operating profit on a LTM basis of £6.6m from revenues of £56.5m.
    • Forward order book of £57.8m remains strong and increased from £41.3m at H1 FY23.
  • Agriculture Division
    • Revenues for the six month period reduced by 7.5% on prior year to £52.8m (H1 2023: £57.1m).
    • Adjusted operating profit for the six month period reduced by 17.4% to £4.9m (H1 2023 restated: £6.0m).
    • UK feed block tonnage increased by 11% year on year whilst the US feed block business volumes were down 18% year on year. The under-performing facility in Nevada has now closed with production requirements transferred to the two remaining sites.
    • US dairy feed supplement business increased volume by 19%, however remains loss making due to unfavourable contracts ending in FY24. New management in situ to return to profitability.
    • UK market cautiously improving as input prices stabilise, whilst US market conditions continue to be challenging due to cyclical herd size reductions and ongoing regional drought condition.
  • Central costs
    • Central costs, on an adjusted basis, of £1.6m (H1 2023 restated: £1.3m).
    • Ongoing cost reduction measures underway in FY24, continuing into H1 FY25, step-changes aligned to strategic direction.
  • Adjusting items
    • £2.3m of adjusting items (pre-tax) comprising:
      • £1.9m of restructuring and other non-recurring cash costs
      • £0.4m in relation to amortisation of intangibles
  • Net cash / debt
    • Half year-end net cash of £8.0m (H1 2023: Net cash £8.6m) – following payment of final dividend for FY23.
  • Dividends
    • Interim dividend of 2.35p per share (H1 2023: 1.175p).
    • Reflecting previously announced policy of a single interim dividend and final, rather than two interims and final.

 

Strategic Highlights

  • Board and management appointments in anticipation of the transformation of the Group:  David White (Chief Executive Officer), Gavin Manson (Chief Financial Officer), Martin Rowland (Executive Director of Transformation), Gillian Watson (Non-Executive Director and Senior Independent Director) and Fiona Rodford (Non-Executive Director).
  • Transformation of Agriculture Division underway with new leadership across global businesses, with Josh Hoopes joining as CEO Agriculture in March supported by new leadership teams in the UK and US.
  • Ongoing cost reduction measures underway in FY24, continuing into H1 FY25, with step changes aligned to strategic direction.
  • Group bank facilities of £25m extended to December 2026.
  • Final £4.0m deferred consideration from the sale of the Agricultural Supplies Division received in October 2023.

Outlook

Trading conditions in agriculture remain challenging, particularly in the US. The Board expects this to continue through the current financial year, while retaining confidence in prospects improving in the medium to long term. Our short-term focus is on ensuring that performance is optimised during persistently challenging conditions whilst making the changes necessary to deliver longer term value creation. The Engineering Division delivered a strong first half performance, building on FY23. The Board remains confident that order book levels will enable year-on-year growth during FY24, while also providing confidence beyond the current financial year.  Board expectations for FY24 remain unchanged.

Quote: David White (Chief Executive Officer)“Having reviewed the position of the Group and its market valuation the Board has concluded that the value of each of our divisions individually, when added together, significantly outweighs our market capitalisation. The growing profitability and future prospects of our Engineering Division make this the optimal time to explore options to realise value for that division. The significant opportunities to improve our market position in our Agriculture Division point to short term focus on optimising trading through challenging conditions and preparing that business for future growth built on the foundation of our leading brands. We now have the team in place to deliver the transformation necessary at divisional and central level.”

Quote: Tim Jones (Chair)‘‘Our strategy of Focus, Improve, Deliver has highlighted the value opportunity that is available from each of our divisions in time. We have concluded that our Engineering Division represents a significant opportunity to deliver incremental value to shareholders now, and that it is the right thing to do to explore that opportunity. And we are excited by the opportunities in the Agriculture Division. Global demand for meat and dairy continues to grow strongly at the same time as the imperative to reduce the climate impact of livestock. The task for Carr’s Agriculture is to reduce the carbon footprint of livestock and enhance animal welfare whilst delivering better margins and productivity for farmers. Carr’s product innovations promote shorter calving intervals, enhance weight gain and help to lower methane emissions. I am delighted that Carr’s now has the people, the products and the market opportunities to rapidly grow our global impact in this space.’’

 

Interim Management Report

Strategic Update

The Board has reviewed the structure and composition of the Group and concluded that both the Engineering and Agriculture Divisions are quality assets demonstrating significant value creation opportunities. Given the scale of the businesses, the complexity resultant from operating two divisions which display no significant synergies has created in an inefficient structure and central organisation.

Current trading as well as the short, medium and long term growth opportunities within the Engineering Division are likely to result in there being a near-term opportunity to deliver attractive value to shareholders.

Following implementation of the ongoing tactical and strategic initiatives developed by management, in combination with the anticipated macro-economic recovery in the sector, the opportunity to develop significant incremental value in the Agriculture Division is longer term.

The Board has, therefore, concluded that it is appropriate to explore the opportunities to realise value for the Engineering Division. A process to explore value is currently in its nascent stages, and further information will be provided in due course.

Interim results

During the six months ended 29 February 2024 revenues increased 2.0% to £81.4m (H1 2023: £79.8m) reflecting growth in Engineering of £5.9m (26.1%), somewhat offset by a reduction in Agriculture revenue of £4.3m (7.5%). Adjusted operating profit for the Group of £5.8m was unchanged from the prior year (H1 2023 restated: £5.8m).  Adjusted profit before tax was unchanged from the prior year at £5.6m (H1 2023 restated: £5.6m).  Adjusted earnings per share for continuing operations decreased by 4.0% to 4.8p (H1 2023 restated: 5.0p) for the six month period.

Operational review

Engineering

The Engineering Division comprises specialist fabrication and precision engineering businesses in the UK, robotics businesses in the UK, Europe and USA, and engineering solutions businesses in the UK and USA.

 

 H1 2024 H1 2023 % Change
Revenue £28.5m £22.6m 26.1%
Adjusted operating profit £2.4m £1.1m 119.2%
Adjusted operating margin 8.6% 4.9% +3.7pp

 

Strength in performance continued from the second half of FY23 with first half revenue of £28.5m, up 26.1% on the prior year. Adjusted operating profit of £2.4m was more than double the prior year, bringing LTM adjusted operating profit to £6.6m, an adjusted operating margin of 11.7% from revenues of £56.5m.

The order book remains strong with £57.8m recorded at the period end, significantly ahead of the £41.3m prior half comparative. Orders since February 2024 have returned the order book above the £59.8m in hand at the end of FY23. This continued strength sets the Engineering Division up well for another strong second half performance, and for further steady growth. 

Fabrication and precision engineering revenues were up 23% in the period, supported by continued high activity levels in the nuclear sector and strong order intake from the oil and gas sector. The businesses in these sectors are increasingly benefitting from the integration of decision making and customer relationship management.

Revenues in the robotics business increased 60.4% from last year, benefitting from the significant order wins last year including a prestigious £10m contract for the UK’s National Nuclear Laboratory, the largest single contract signed by Wälischmiller.

Management is confident in the outlook for the Engineering Division in the second half and beyond the current financial year. The division has confirmed high value contracts continuing into FY25 and beyond, and a well-balanced spread of current orders across all the business units in the division. The pipeline of opportunities and prospects beyond confirmed orders is very encouraging. The Engineering Division is increasingly focused on the specific opportunities that match its market leading skills, technical strengths and high-quality manufacturing assets and is benefitting from long term CRM activity aligned across the division.

Agriculture

The Agriculture Division manufactures livestock supplements including branded feed blocks, essential minerals, and precision dose trace element boluses, sold to farmers in the UK, Europe, North America, and New Zealand through a long-established distribution network.

 

 H1 2024 H1 2023 (restated) % Change
Revenue £52.8m £57.1m (7.5%)
Adjusted operating profit £4.9m £6.0m (17.4%)
Adjusted operating margin 9.4% 10.5% -1.1pp

 

With challenging conditions continuing in the agriculture sector, revenues decreased by 7.5% in the period. This was largely driven by the high inflationary and reduced volume environment of FY23 that saw average feed block prices increase by 21% but feed block volumes decrease by 16%. In H1 FY24 the UK has returned to volume growth (+11% year on year) whilst the US feed blocks business has seen further year on year decline (18%) as herd sizes continue to decrease cyclically, accentuated by continued drought in the southern states.

Encouragingly, at Animax (the UK animal health business acquired in 2018), transformational automation of the production process was implemented late in the first half of FY24. The benefits of this automation on each of capacity, cost and specification accuracy will be apparent in the second half. Prior to these improvements being evident first half performance was broadly flat year on year.

Our New York State based dairy cattle feed supplement business recorded volume growth of 19% in the first half but remains loss making. Actions to raise margins and achieve profitability are in progress.  

With new management now in situ we maintain a positive longer-term outlook for the Agriculture Division from both an internal operational effectiveness perspective and in terms of macro-economic conditions. In the UK and Ireland, farm input prices, particularly for feed and fertiliser, are coming down, easing the pressure on customer spending budgets. Farm input and output price indices have matched in early 2024 for the first time since Q2 2021, with input prices having been over 15% higher than outputs in Q3 2022. These increasingly positive macro-economic trends have translated to volume increases but have yet to result in improved margins.  In the USA, the area affected by drought is markedly reduced from 12 months previously, whilst the cyclical outlook specifically for beef will improve as herds rebuild over the next five years.

Management actions already underway at the UK animal health business coupled with the progress at the other Agriculture businesses will result in improved financial performance and increased resilience over time. The Agriculture businesses are founded on respected brands with a track record of quality, innovation and service, that will ultimately support sales and margins as markets recover from recent unprecedented conditions.

Adjusted results

Revenue increased by 2.0% to £81.4m (H1 2023: £79.8m), with a year on year increase of 26.1% in Engineering offset by a reduction of 7.5% in Agriculture.

Adjusted operating profit was unchanged at £5.8m (H1 2023 restated: £5.8m). Engineering grew by 119.2% offset by a 17.4% reduction in Agriculture.

Central costs, on an adjusted basis, were £0.3m higher at £1.6m (H1 2023 restated: £1.3m) driven by the impact of inflationary pay increases in the prior year and costs associated with the completion of strategic projects.

Net finance costs of £0.1m (H1 2023: £0.2m) were slightly lower than the prior period. Higher interest rates were offset by lower borrowings across the period after existing facilities were reduced using consideration received from the sale of the Carr’s Billington business.

The Group’s adjusted profit before tax was unchanged at £5.6m (H1 2023 restated: £5.6m). Adjusted earnings per share decreased by 4.0% to 4.8p (H1 2023: restated 5.0p).

Adjusting items

The Group provides the adjusted profit measures referred to above to present additional useful information on business performance consistent with how business performance is measured internally. These measures show underlying profits before certain adjusting items. Adjusting items related to continuing operations during the period were a net charge before tax of £2.2m (H1 2023: £0.6m), with full details included in note 8.

Statutory results

Reported operating profit on a statutory basis was £3.5m (H1 2023 restated: £5.2m) and reported profit before tax was £3.4m (H1 2023 restated: £5.0m). Basic earnings per share on a statutory basis was 3.0p (H1 2023: restated 4.5p).

Balance sheet and cash flow

Net cash generated from operating activities in continuing operations in the first half was £5.5m (H1 2023: £3.6m). Cash generated from continuing operations in the period of £4.3m was ahead of the same period last year (cash generated of £4.0m).

Excluding leases, the Group moved from net cash of £4.2m at the financial year end to net cash of £8.0m at 29 February 2024. This change has been driven by receipt of the £4.0m deferred consideration related to the sale of the Carr’s Billington Agriculture business.

The Group’s defined benefit pension scheme remains in surplus, with a balance of £5.9m compared to £5.3m at 2 September 2023.  The Trustees are in discussion with insurers regarding a potential buy-in of the scheme.

Shareholders’ equity at 29 February 2024 was £107.7m (2 September 2023: £107.9m).

An interim dividend of 2.35 pence per ordinary share will be paid on 5 June 2024 to shareholders on the register on 3 May 2024. The ex-dividend date will be 2 May 2024. The increased dividend of 2.35p reflects the previously announced updated policy of a single interim dividend and final rather than two interims and final dividend.

Outlook

Trading conditions in agriculture remain challenging, particularly in the US. The Board expects this to continue through the current financial year, while retaining confidence in prospects improving in the medium to long term. Our short-term focus is on ensuring that performance is optimised during persistently challenging conditions whilst making the changes necessary to deliver longer term value creation. The Engineering Division delivered a strong first half performance, building on FY23. The Board remains confident that order book levels will enable year on year growth during FY24, while also providing confidence beyond the current financial year.  Board expectations for FY24 remain unchanged.

Principal risks and uncertainties

The Group has a process in place to identify and assess the impact of risks on its business, which is reviewed and updated regularly. The principal risks and uncertainties for the remainder of the financial year are not considered to have changed materially from those included on pages 20 to 23 of the Annual Report and Accounts 2023 (available on the Company’s website at http://investors.carrsgroup.com).

CONDENSED CONSOLIDATED INCOME STATEMENT
For the 6 months ended 29 February 2024

  6 months ended
29 February
2024
(unaudited)
6 months ended
4 March
2023
(unaudited) (restated)2
Year ended
2 September
2023
(audited)
Notes £’000 £’000 £’000
Continuing operations     
Revenue 6,7 81,372 79,754 143,214
Cost of sales  (63,574) (62,032) (110,924)
     
Gross profit  17,798 17,722 32,290
     
Net operating expenses  (15,627) (14,105) (31,780)
Share of post-tax results of joint ventures 6 1,369 1,596 1,441
     
Adjusted¹ operating profit 6 5,758 5,839 7,950
Adjusting items 8 (2,218) (626) (5,999)
Operating profit 6 3,540 5,213 1,951
     
Finance income  630 382876
Finance costs  (745) (609)(1,320)
     
Adjusted¹ profit before taxation 6 5,643 5,6127,506
Adjusting items 8 (2,218) (626)(5,999)
Profit before taxation 6 3,425 4,9861,507
     
Taxation  (606) (769)(1,111)
Adjusted¹ profit for the period from continuing operations  4,508 4,6955,836
Adjusting items 8 (1,689) (478)(5,440)
  
Profit for the period from continuing operations 2,819 4,217396
  
Discontinued operations   
Profit/(loss) for the period from discontinued operations 9 - 214(1,157)
Profit/(loss) for the period 2,819 4,431 (761)
Profit/(loss) attributable to:   
Equity shareholders 2,819 4,217(226)
Non-controlling interests3 - 214(535)
2,819 4,43 (761)
  
Earnings per ordinary share (pence)   
Basic     
Profit from continuing operations 10 3.0 4.5 0.4
Loss from discontinued operations 10 - - (0.7)
 10 3.0 4.5 (0.3)
Diluted     
Profit from continuing operations 10 3.0 4.4 0.4
Loss from discontinued operations 10 - - (0.7)
 10 3.0 4.4 (0.3)
     

 

 

1      Adjusted results are consistent with how business performance is measured internally and is presented to aid comparability of performance. Adjusting   items are discussed in note 8. An alternative performance measures glossary can be found in note 20.

2      See notes 9 and 19 for an explanation of the prior period restatements to the period ended 4 March 2023 recognised in relation to the measurement of fair value less costs to sell of the disposal group.

3      Non-controlling interests relate to businesses included in the disposal group.

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
For the 6 months ended 29 February 2024

  6 months ended
29 February 2024)
(unaudited)
6 months ended
4 March 2023
(unaudited) (restated)
Year ended
2 September 2023
(audited)
Notes £’000) £’000) £’000
     
    
     
Profit/(loss) for the period  2,819 4,431(761)
     
Other comprehensive income/(expense)     
    
Items that may be reclassified subsequently to profit or loss:     
Foreign exchange translation gains/(losses) arising on
  translation of overseas subsidiaries
  
60
 
(666)
 
(3,141)
     
Items that will not be reclassified subsequently to profit or loss:     
Actuarial gains/(losses) on retirement benefit asset:     
- Group 15 598 (1,445) (2,058)
- Share of associate (discontinued operations)  - - (717)
     
Taxation (charge)/credit on actuarial gains/(losses) on retirement benefit asset:     
- Group  (150) 361 515
- Share of associate (discontinued operations)  - - 179
     
Other comprehensive income/(expense) for the period, net of tax 508 (1,750) (5,222)
     
Total comprehensive income/(expense) for the period  3,327 2,681 (5,983)
     
Total comprehensive income/(expense) attributable to:  
Equity shareholders 3,327 2,467 (5,448)
Non-controlling interests[1] - 214 (535)
 
3,327 2,681 (5,983)
 
Total comprehensive income/(expense) attributable to:  
Continuing operations 3,327 2,467 (4,288)
Discontinued operations - 214 (1,695)
  
3,327 2,681 (5,983)

 

1   Non-controlling interests relate to businesses included in the disposal group.

2   See notes 9 and 19 for an explanation of the prior period restatements to the period ended 4 March 2023 recognised in relation to the measurement of fair value less costs to sell of the disposal group.

 

CONDENSED CONSOLIDATED BALANCE SHEET
As at 29 February 2024

  As at
29 February 2024
(unaudited)
As at
4 March 2023
(unaudited)   (restated)1
As at
2 September 2023
(audited)
Notes   £’000)  £’000   £’000
Non-current assets     
Goodwill 12 19,192 23,351 19,161
Other intangible assets 12 3,028 4,277 3,318
Property, plant and equipment 12 29,902 30,694 29,950
Right-of-use assets 12 7,112 7,891 7,323
Investment property 12 2,600 2,680 2,640
Interest in joint ventures  7,475 7,525 6,101
Other investments  27 31 27
Contract assets  - 316 -
Financial assets     
- Non-current receivables  21 23 21
Retirement benefit asset 15 5,884 5,874 5,316
Deferred tax asset  26 205 26
  75,267 82,867 73,883
     
Current assets     
Inventories  22,622 24,856 26,613
Contract assets  10,390 7,124 7,915
Trade and other receivables  24,186 27,479 24,592
Current tax assets  2,374 3,133 3,895
Financial assets     
- Cash and cash equivalents 13 21,581 23,493 23,123
  81,153 86,085 86,138
     
Total assets  156,420 168,952 160,021
     
Current liabilities     
Financial liabilities     
- Borrowings 13 (8,718) (9,392) (13,714)
- Leases  (1,471) (1,325) (1,264)
- Derivative financial instruments  - (41) (4)
Contract liabilities  (4,769) (3,165) (5,194)
Trade and other payables  (18,883) (19,240) (16,556)
Current tax liabilities  (55) (166) (131)
  (33,896) (33,329) (36,863)
Non-current liabilities     
Financial liabilities     
- Borrowings 13 (4,894) (5,470) (5,206)
- Leases  (5,085) (5,769) (5,559)
Deferred tax liabilities  (4,844) (4,648) (4,447)
Other non-current liabilities  (15) (233) (71)
  (14,838) (16,120) (15,283)
     
Total liabilities (48,734) (49,449) (52,146)
 
Net assets  107,686 119,503 107,875
     
Shareholders’ equity  
Share capital 16 2,359 2,351 2,354
Share premium 16 10,862 10,522 10,664
Other reserves 3,506 6,121 3,581
Retained earnings 90,959 100,509 91,276
Total shareholders’ equity 107,686 119,503 107,875

 

 

1  See notes 9 and 19 for an explanation of the prior period restatements to the period ended 4 March 2023 recognised in relation to the measurement of fair value less costs to sell of the disposal group.

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the 6 months ended 29 February 2024

 
Share
Capital

Share
Premium
Treasury
Share
Reserve
Equity
Compensation
Reserve
Foreign
Exchange
Reserve

Other
Reserve

Retained
Earnings
Total
Shareholders’
Equity
Non-
Controlling

Interests

Total
Equity
   £’000 £’000 £’000   £’000   £’000   £’000   £’000 £’000   £’000   £’000
At 3 September 2023 (audited) 2,354  10,664  -  264 3,127 190 91,276 107,875 - 107,875
Profit for the period -  -  - - - - 2,819 2,819 - 2,819
Other comprehensive income- - - - 60 - 448   508 -   508
Total comprehensive income - - - - 60 - 3,267 3,327 - 3,327
Dividends paid -  -  -  - - - (3,788)  (3,788) -  (3,788)
Equity-settled share-based payment transactions -  -  - 143 - - -   143 -   143
Allotment of shares5 198  - - - - -   203 -   203
Purchase of own shares held in trust -  -   (74) - - - - (74) - (74)
Transfer -  -  49  (251) - (2) 204 - - -
At 29 February 2024 (unaudited) 2,359  10,862   (25) 156 3,187 188 90,959 107,686 - 107,686
 
As previously reported at 3 September 2022 (unaudited)¹ 2,350  10,500  -  528 6,268 192 99,318 119,156 14,585 133,741
Prior period adjustment² -  -  - - - - (1,023) (1,023) (389)  (1,412)
At 4 September 2022 (audited) (restated)² 2,350  10,500  -  528 6,268 192 98,295 118,133 14,196 132,329
Profit for the period (restated)² -  -  - - - - 4,217 4,217 214 4,431
Other comprehensive expense -  -  - - (666) - (1,084)  (1,750) -  (1,750)
Total comprehensive (expense)/income (restated)² -  -  - - (666) - 3,133 2,467 214 2,681
Dividends paid -  -  - - - - (1,104)  (1,104) -  (1,104)
Equity-settled share-based payment transactions -  -  - (16) - - - (16) - (16)
Allotment of shares 1 22   -  - - - -  23 -  23
Sale of disposal group -  -  - - - - - - (14,410)  (14,410)
Transfer -  -  - (184) - (1) 185 - - -
At 4 March 2023 (unaudited) (restated)² 2,351  10,522  -  328 5,602 191 100,509 119,503 - 119,503
           
At 4 September 2022³ (audited) 2,350  10,500  -  528 6,268 192 98,295 118,133 14,196 132,329
Loss for the period -  -  - - - - (226) (226) (535) (761)
Other comprehensive expense -  -  - -  (3,141) - (2,081) (5,222) -  (5,222)
Total comprehensive expense -  -  - -  (3,141) - (2,307) (5,448) (535)  (5,983)
Dividends paid  -  -  - - - - (4,889) (4,889) -  (4,889)
Equity-settled share-based payment transactions -  -  - (85) - - - (85) (7) (92)
Excess deferred taxation on share-based payments -  -  - - - - (4) (4) - (4)
Allotment of shares 4 164  -   - - - - 168 -   168
Sale of disposal group -  -  - - - - - - (13,654)  (13,654)
Transfer -  -  - (179) - (2) 181 - - -
At 2 September 2023 (audited)  2,354  10,664  -  264 3,127   190 91,276 107,875 - 107,875

 

1 As reported in the Interim Report for the half year ended 4 March 2023.

2 See notes 9 and 19 for an explanation of the prior period restatements to the period ended 4 March 2023 recognised in relation to the measurement of fair value less costs to sell of the disposal group.

3 Previously restated in the Annual Report and Accounts for the year ended 2 September 2023.

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
For the 6 months ended 29 February 2024

  6 months ended
29 February 2024
(unaudited)
6 months ended
4 March 2023
 (unaudited)  
Year ended
2 September 2023
(audited)
Notes  £’000) £’000 £’000
Cash flows from operating activities     
Cash generated from continuing operations 17 4,334 4,040   3,155
Interest received  489 225 564
Interest paid  (745)  (663)  (1,320)
Tax received/(paid)  1,454  (38)  (278)
Net cash generated from operating activities in continuing operations 5,532 3,564   2,121
Net cash used in operating activities in discontinued operations -  (2,952)  (3,040)
Net cash generated from/(used in) operating activities  5,532 612  (919)
    
Cash flows from investing activities     
Sale of disposal group (net of cash disposed and costs to sell)  4,000 24,341 25,619
Dividends received from joint ventures  - -   1,390
Purchase of intangible assets  (5)  (157)  (193)
Proceeds from sale of property, plant and equipment  3 - 48
Purchase of property, plant and equipment   (1,330)  (1,970)  (3,194)
Net cash generated from investing activities in continuing operations  2,668 22,214 23,670
Net cash used in investing activities in discontinued operations -  (604)  (487)
Net cash generated from investing activities  2,668 21,610 23,183
    
Cash flows from financing activities     
Proceeds from issue of ordinary share capital  203 23 167
Purchase of own shares held in trust  (74) - -
New financing and drawdowns on RCF  (75)   4,741   5,574
Repayment of RCF drawdowns  -  (21,741)  (21,741)
Lease principal repayments  (684)  (764)  (1,545)
Repayment of borrowings  (1,127)  (4,011)  (4,263)
Dividends paid to shareholders  (3,788)  (1,104)  (4,889)
Net cash used in financing activities in continuing operations  (5,545)  (22,856)  (26,697)
Net cash used in financing activities in discontinued operations -  (9,599)  (9,599)
Net cash used in financing activities  (5,545)  (32,455)  (36,296)
     
Effects of exchange rate changes  (36) 33  (54)
Net increase/(decrease) in cash and cash equivalents  2,619  (10,200)  (14,086)
Cash and cash equivalents at beginning of the period  10,769 24,856 24,855
Cash and cash equivalents at end of the period  13,388 14,656 10,769
    
Cash and cash equivalents consist of:     
Cash and cash equivalents per the balance sheet  21,581 23,493 23,123
Bank overdrafts included in borrowings  (8,193)  (8,837)  (12,354)
  13,388 14,656 10,769

 

Statement of Directors’ responsibilities

The Directors confirm that these condensed consolidated interim financial statements have been prepared in accordance with UK-adopted International Accounting Standard 34, ‘Interim Financial Reporting’ and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom’s Financial Conduct Authority and that the interim management report includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:

  • an indication of important events that have occurred during the first six months of the year and their impact on the condensed set of interim financial statements, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and
  • material related party transactions in the first six months of the year and any material changes in the related party transactions described in the last Annual Report.

The Directors are listed in the Annual Report and Accounts 2023 with the exception of Fiona Rodford who joined the Board on 20 February 2024. The following changes to the Board took place in the period: Gillian Watson was appointed to the Board on 9 October 2023, John Worby stepped down from the Board on 31 October 2023, Peter Page stepped down from the Board on 17 November 2023 and Fiona Rodford was appointed to the Board on 20 February 2024. In addition, former CFO David White became CEO from 17 November 2023, and former Non-Executive Director Martin Rowland became Executive Director of Transformation from 13 November 2023. A list of current Directors is maintained on the website: www.carrsgroup.com

 

On behalf of the Board

Tim Jones 
Chair 
18 April 2024

David White
Chief Executive Officer
18 April 2024